/
Treatment Emergent Definitions Recommendations
Treatment Emergent Definitions Recommendations
- Former user (Deleted)
- Nicola Newton
- Former user (Deleted)
Owned by Former user (Deleted)
Project Scope |
This Project team will create a White Paper with recommendations for Treatment Emergent Definitions, with a focus on Phase 2-4 clinical trials. This White Paper will build upon a White Paper that outlines results from a survey on current practices, indicating variation that can likely be reduced. Recommendations will be based on the desired end-in-mind, and may or may not be consistent with current practices. |
| Project Leads | Emails |
|---|---|
William Palo, Abbvie | |
Nicola Newton, PHUSE Project Assistant |
CURRENT STATUS Q3 2024 |
|---|
|
Objectives & Deliverables | Timelines |
|---|---|
White Paper - Recommended Definition of Treatment-Emergent Adverse Events in Clinical Trials' | Q3 2024 |
, multiple selections available,
Related content
Recommendations for Adverse Event Collection and Treatment Emergent Definition
Recommendations for Adverse Event Collection and Treatment Emergent Definition
More like this
Listings for Clinical Study Report
Listings for Clinical Study Report
More like this
RWD for Regulatory Decision-Making: Learnings from Use Cases and Demonstration Projects
RWD for Regulatory Decision-Making: Learnings from Use Cases and Demonstration Projects
More like this
Adverse Event Collection Recommendations
Adverse Event Collection Recommendations
More like this